Thursday, January 31, 2013

From Wall Street to Biotech

A biotechnology and life-sciences investor with numerous achievements in his field, Lindsay Rosenwald serves as one of two founding partners of Opus Point Partners, an asset management firm in the healthcare sector. Raised in Pennsylvania, Dr. Rosenwald graduated from Abington Senior High School before enrolling at Penn State University, where he pursued studies in finance and economics. An outstanding student and member of the Beta Gamma Sigma honor society, Lindsay Rosenwald graduated from Penn State with a Bachelor of Science in 1976 and subsequently became an independent management consultant for the burgeoning healthcare industry. From there, he gained admission to the Temple University School of Medicine, earned his Doctor of Medicine in 1983, and completed his clinical training in internal medicine at Abington Memorial Hospital. After a period in private practice, Lindsay Rosenwald returned to the business world and began a prolific career in the investment and management of promising drug development companies.

Having worked on Wall Street in the mid-1980s, Lindsay Rosenwald became a hugely successful venture capitalist in the Biotech space. To date, Dr. Rosenwald and his companies have licensed and further developed over one hundred drug candidates. More information on Lindsay Rosenwald and his work can be found at